Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Pancreatic Neoplasms 1 Lymphedema 1 Locally Advanced Rectal Cancer 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Esophageal Cancer 1 Advanced Breast Cancer 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Combined Modality Therapy × Clear all

NCT04718701 2021-08-16

ATNPA

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡